BORCS5
BLOC-1-related complex subunit 5
Also known as: BORC5_HUMAN, LOH12CR1, LOH1CR12
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q969J3
- Gene
- BORCS5
- Ensembl
- ENSG00000165714
- Chromosome
- 12
- Canonical length
- 196 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Vesicles,Plasma membrane
OverviewNCBI Gene
Involved in lysosome localization and organelle transport along microtubule. Located in cytoplasmic side of lysosomal membrane; plasma membrane; and plus-end kinesin complex. Part of BORC complex. Implicated in colorectal adenocarcinoma. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
196 residues, UniProt reviewed canonical sequence.
>Q969J3|BORCS5
1 MGSEQSSEAE SRPNDLNSSV TPSPAKHRAK MDDIVVVAQG SQASRNVSND PDVIKLQEIP
61 TFQPLLKGLL SGQTSPTNAK LEKLDSQQVL QLCLRYQDHL HQCAEAVAFD QNALVKRIKE
121 MDLSVETLFS FMQERQKRYA KYAEQIQKVN EMSAILRRIQ MGIDQTVPLL DRLNSMLPEG
181 ERLEPFSMKP DRELRLLocalizationUniProt · AlphaFold · HPA
Whether an antibody against BORCS5 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.57
- Highest tissue expression
- 11 nTPM
Expression across tissuesHPA
Tissue
- blood vessel: 11 nTPM
- spinal cord: 11 nTPM
- midbrain: 10 nTPM
- basal ganglia: 9.2 nTPM
- hypothalamus: 9.1 nTPM
- cerebral cortex: 8.8 nTPM
Single-cell type
- oligodendrocytes: 144 nCPM
- choroid plexus epithelial cells: 75 nCPM
- podocytes: 73 nCPM
- other brain neurons: 71 nCPM
- brain inhibitory neurons: 68 nCPM
- brain excitatory neurons: 60 nCPM
Immune cell
- T-reg: 14 nTPM
- NK-cell: 12 nTPM
- MAIT T-cell: 12 nTPM
- memory CD4 T-cell: 12 nTPM
- memory CD8 T-cell: 11 nTPM
- intermediate monocyte: 10 nTPM
Brain region
- white matter: 24 nTPM
- basal ganglia: 22 nTPM
- cerebral cortex: 22 nTPM
- pons: 21 nTPM
- hypothalamus: 20 nTPM
- medulla oblongata: 20 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about BORCS5.
Disease | GeneticClinVar
1 pathogenic / likely-pathogenic of 37 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- BORCS5-related disorder
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.13
- gnomAD pLI
- 0
- DepMap mean gene effect
- -0.12
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 7% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- lysosome localization
- nervous system development
- organelle transport along microtubule
- positive regulation of anterograde synaptic vesicle transport
- regulation of endosome size
- regulation of lysosome size
Cellular components
Protein domainsUniProt · Pfam · InterPro
- BLOC-1-related complex subunit 5
- Tumour suppressor protein
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of BORCS5 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads BORCS5 as an antibody target. Whether an autoantibody or antibody against BORCS5 could matter depends on whether native BORCS5 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
BORCS5 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label BORCS5 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...